June 2026 Research Brief
Active sponsors
Trials
A Trial in Healthy Adult Participants and Adults With Autoimmune Disease to Test How HBM7020 is Tolerated and Absorbed in the Body
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
Reduced Vaccine Response to HZ/su in SLE
To Evaluate the Effects of Cevostamab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis
Evaluation of Safety, Pharmacokinetics and Pharmacodynamics of Arnovie101, an mRNA-LNP-Based In Vivo CAR-T Therapy, for the Treatment of B Cell-Mediated Autoimmune Diseases (SLE and AIHA)
A Study to Investigate Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Anifrolumab in Pediatric Participants 5 to < 18 Years of Age With Systemic Lupus Erythematosus
The Effect of Exercise on Cognitive Functions in Individuals With Systemic Lupus Erythematosus
IASO207 Injection for Active Refractory Systemic Lupus Erythematosus (SLE)
Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)
Showing trials with activity in the past 30 days. See the full Lupus research landscape →
Condition guide
Lupus — the full picture
Research landscape, trial types, and what eligibility typically looks like — written for patients but useful for everyone.
Monthly digest
Get this brief every month
We’ll email you the Lupusbrief as soon as it’s published — no login required.
Coming soon